source
- Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s AbogenNovartis is licensing an mRNA-based therapy designed to produce a CD3xCD19 T cell engager inside the body. Abogen Biosciences says the in vivo approach could reduce the likelihood of dangerous cyto…BioSpace · 1mo ago↗ source
- Medicare Advantage plans to raise out-of-pocket costs and cut benefits for 2027 enrolleesMedicare Advantage insurers are set to increase out-of-pocket expenses for seniors enrolling in 2027 plans. The changes include higher cost‑sharing, reduced coverage for dental and other services,…
- Science journal launches special issue on women’s health, spotlighting menopause and chronic pain